RCAP
PRCT icon

Resolute Capital Asset Partners’s Procept Biorobotics PRCT Stock Holding History

Resolute Capital Asset Partners’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-45,000
Closed -$1.28M – 50
2023
Q1 		$1.28M Buy
+45,000
New +$1.59M 0.93% 34

Other funds holding PRCT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CI
CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Resolute Capital Asset Partners's PRCT Position: Q2 2023 in Review

Resolute Capital Asset Partners sold out of Procept Biorobotics (PRCT) in Q2 2023, closing a stake of 45,000 shares — an estimated $1.28M sold.

Resolute Capital Asset Partners first reported a position in PRCT in Q1 2023 and held it in 1 quarter. The position peaked at $1.28M in Q1 2023. 120 funds tracked by Wall St. Rank hold PRCT as of Q2 2023.

  • Resolute Capital Asset Partners reported no remaining Procept Biorobotics position as of Q2 2023 after selling out during the quarter.
  • Resolute Capital Asset Partners sold 45,000 Procept Biorobotics shares in Q2 2023, an estimated $1.28M.
  • Resolute Capital Asset Partners first reported a position in Procept Biorobotics in Q1 2023 and held it in 1 quarter.
  • Resolute Capital Asset Partners's Procept Biorobotics position peaked at $1.28M in Q1 2023.
  • 120 funds tracked by Wall St. Rank held Procept Biorobotics as of Q2 2023.

Based on Resolute Capital Asset Partners's 13F filing for Q2 2023, filed 14 Aug 2023.